6 tulemused
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present disclosure relates to novel use of compounds isolated from Euphorbia neriifolia for manufacturing a medicament or a pharmaceutical composition for treating cancer and/or thrombocytopenia.
2. Description of Related Art
The leaves
This invention relates to a compound or croup or compounds present in an active principle derived from the family Euphorbiaceae, and in particular in plants of the species Euphorbia peplus, Euphorbia hirta and Euphorbia drummondii. Extracts from these plants have been found to show selective
This invention relates to a compound or group of compounds present in an active principle derived from the family Euphorbiaceae, and in particular in plants of the species Euphorbia peplus, Euphorbia hirta and Euphorbia drummondii. Extracts from these plants have been found to show selective
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application was filed under 35 U.S.C. .sctn.371 based on PCT/AU98/00656, filed on Aug. 19, 1998, which claims the benefit of priority to Australian Application No. PO-8640, filed Aug. 19, 1997. These applications are explicitly incorporated herein
TECHNICAL FIELD OF THE INVENTION
This invention generally relates to compounds for treating cancer that are derived from plants and, in particular, the isolation and use of an extract from a Euphorbia obesa plant having anti-tumor effects on a variety of cancerous cell.
BACKGROUND
Plants and marine
This invention relates to a compound or group of compounds present in an active principle derived from the family Euphorbiaceae, and in particular in plants of the species Euphorbia peplus, Euphorbia hirta and Euphorbia drummondii. Extracts from these plants have been found to show selective